Skip to content
healthcare.dev
Get a free key

Darifenacin

NDC 69097-431, Darifenacin Hydrobromide, tablet, extended release, from Cipla USA Inc..

Product NDC
69097-431
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207664
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-431 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARIFENACIN HYDROBROMIDE7.5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
69097-431-026909704310230 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02)
69097-431-056909704310590 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05)
69097-431-15690970431151000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6e8470d1-c3e6-4644-b70a-aa47ddf79676

  • NADAC price for package 69097043102

    GET /v1/drugs/nadac/69097043102

  • NADAC price for package 69097043105

    GET /v1/drugs/nadac/69097043105

Use it

Look up 69097-431 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-431 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-431. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.